A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive ...

Small cell lung cancer (SCLC), one of the deadliest types of lung cancer, is an aggressive tumor that metastasizes early compared to other cancers and can quickly develop resistance to chemotherapy — ...

Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.

A new study has found a commonly prescribed anti-nausea medication is associated with better prognosis for women with early-stage breast cancer, particularly triple negative breast cancer.

New preclinical research shows a promising drug combination that targets ovarian cancer’s survival pathways, paving the way ...

A new study out of the University of Minnesota's Hormel Institute looked at how dopamine can play a role in treating lung cancer. The study, published in the journal Cell Death & Disease, focused on ...

An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims more than ...

They want to gain a deeper understanding of why the disease behaves differently in Asian patients. Read more at ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated ...

SINGAPORE: Researchers in Singapore have received a S$25 million grant to work on tackling lung cancer in Asian patients ...

Anecdotal and epidemiological evidence has also suggested that people taking statins regularly may have a lower risk of developing solid tumours such as colorectal or breast cancer ...